• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

辉瑞新冠疫苗接种后获得性血栓性血小板减少性紫癜

Acquired thrombotic thrombocytopenic purpura following Pfizer COVID-19 vaccination.

作者信息

Alislambouli Mawaddah, Veras Victoria Andy, Matta Jyoti, Yin Faye

机构信息

Department of Medicine Jersey City Medical Center Jersey City New Jersey USA.

出版信息

EJHaem. 2021 Nov 16;3(1):207-210. doi: 10.1002/jha2.342. eCollection 2022 Feb.

DOI:10.1002/jha2.342
PMID:34909764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8657522/
Abstract

Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease and has occasionally been described after vaccination, especially against viral agents. We present a case of a patient who presents with the classic pentad of TTP a few days after receiving the first dose of the mRNA Pfizer COVID-19 vaccine. To our knowledge, this is the second report of a de novo TTP following mRNA Pfizer COVID-19 vaccination.

摘要

获得性血栓性血小板减少性紫癜（aTTP）是一种罕见疾病，在接种疫苗后偶有报道，尤其是针对病毒制剂的疫苗。我们报告一例患者，在接种第一剂辉瑞mRNA新冠疫苗几天后出现了典型的血栓性血小板减少性紫癜五联征。据我们所知，这是第二例接种辉瑞mRNA新冠疫苗后新发血栓性血小板减少性紫癜的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a3/9175738/6e1de0f2eafd/JHA2-3-207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a3/9175738/d5d35a659813/JHA2-3-207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a3/9175738/6e1de0f2eafd/JHA2-3-207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a3/9175738/d5d35a659813/JHA2-3-207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50a3/9175738/6e1de0f2eafd/JHA2-3-207-g001.jpg

相似文献

1
Acquired thrombotic thrombocytopenic purpura following Pfizer COVID-19 vaccination.辉瑞新冠疫苗接种后获得性血栓性血小板减少性紫癜
EJHaem. 2021 Nov 16;3(1):207-210. doi: 10.1002/jha2.342. eCollection 2022 Feb.
2
First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.首例接种 SARS-CoV-2 疫苗后发生的血栓性血小板减少性紫癜 - 病例报告。
BMC Nephrol. 2021 Dec 11;22(1):411. doi: 10.1186/s12882-021-02616-3.
3
Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review.接种 BNT162b2 新冠疫苗后获得性血栓性血小板减少性紫癜：病例报告和文献复习。
Lab Med. 2022 Nov 3;53(6):e145-e148. doi: 10.1093/labmed/lmac016.
4
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.首例与基于 mRNA 的抗 COVID-19 疫苗接种相关的新发免疫性血小板减少性紫癜（iTTP）发作。
J Thromb Haemost. 2021 Aug;19(8):2014-2018. doi: 10.1111/jth.15418. Epub 2021 Jul 5.
5
COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.新型冠状病毒肺炎疫苗（信使核糖核酸BNT162b2）与青少年新型冠状病毒肺炎感染诱发的血栓性血小板减少性紫癜
Pediatr Blood Cancer. 2022 Jun;69(6):e29681. doi: 10.1002/pbc.29681. Epub 2022 Apr 4.
6
Acquired thrombotic thrombocytopenic purpura after AstraZeneca vaccine: A case report.阿斯利康疫苗接种后获得性血栓性血小板减少性紫癜：一例报告。
Caspian J Intern Med. 2022;13(Suppl 3):299-302. doi: 10.22088/cjim.13.0.299.
7
Thrombotic Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Multiple Myeloma: Case Report and Literature Review.一名多发性骨髓瘤患者接种辉瑞-生物科技公司新冠疫苗后发生血栓性血小板减少性紫癜：病例报告及文献综述
Cureus. 2023 Oct 10;15(10):e46784. doi: 10.7759/cureus.46784. eCollection 2023 Oct.
8
Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report.ChAdOx1 nCov-19疫苗接种后发生血栓性血小板减少性紫癜：一例报告
IDCases. 2023 May 8;32:e01795. doi: 10.1016/j.idcr.2023.e01795. eCollection 2023.
9
Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.灭活新冠疫苗接种后获得性血栓性血小板减少性紫癜：两例报告及文献综述
Vaccines (Basel). 2022 Jun 24;10(7):1012. doi: 10.3390/vaccines10071012.
10
Acute Thrombotic Thrombocytopenic Purpura: Rare and Life-Threatening Side Effect of Recent BNT-162b2 COVID-19 Vaccination.急性血栓性血小板减少性紫癜：近期BNT-162b2新冠疫苗接种罕见且危及生命的副作用
HCA Healthc J Med. 2022 Dec 30;3(6):343-348. doi: 10.36518/2689-0216.1384. eCollection 2022.

引用本文的文献

1
A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID-19 Vaccination.血管损伤的系统评价：新冠疫苗接种后危急情况下瘀点、紫癜和瘀斑的综述
Health Sci Rep. 2025 Mar 12;8(3):e70503. doi: 10.1002/hsr2.70503. eCollection 2025 Mar.
2
Immune Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, Therapy and Open Issues.免疫性血栓性血小板减少性紫癜：病理生理学、诊断、治疗及未解决的问题。
Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024060. doi: 10.4084/MJHID.2024.060. eCollection 2024.
3
Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac.

本文引用的文献

1
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.血栓性血小板减少性紫癜：COVID-19 bnt162b2 疫苗接种后的新威胁
Int J Hematol. 2021 Nov;114(5):626-629. doi: 10.1007/s12185-021-03190-y. Epub 2021 Jul 15.
2
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccine.获得性血栓性血小板减少性紫癜，可能与阿斯利康-牛津新冠疫苗有关。
EJHaem. 2021 May 18;2(3):534-536. doi: 10.1002/jha2.219. eCollection 2021 Aug.
3
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
与科兴中维新冠疫苗相关的获得性免疫性血栓性血小板减少性紫癜（TTP）。
Front Med. 2024 Aug;18(4):744-751. doi: 10.1007/s11684-023-1054-2. Epub 2024 Jul 3.
4
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) - Time to think beyond thrombosis with thrombocytopenia syndrome (TTS).基于mRNA的新型冠状病毒2型疫苗（BNT162b2）接种后的血栓形成——是时候超越血小板减少综合征（TTS）相关血栓形成进行思考了。
Thromb Update. 2022 May;7:100104. doi: 10.1016/j.tru.2022.100104. Epub 2022 Apr 18.
5
Covid-19 vaccination in patients with immune-mediated thrombotic thrombocytopenic purpura: a single-referral center experience.免疫性血小板减少性紫癜患者的新冠病毒疫苗接种：单转诊中心经验
Haematologica. 2023 Jul 1;108(7):1957-1959. doi: 10.3324/haematol.2022.282311.
6
Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine.接种mRNA-1273新冠疫苗后血栓性血小板减少性紫癜复发
J Community Hosp Intern Med Perspect. 2022 Jul 4;12(4):80-84. doi: 10.55729/2000-9666.1073. eCollection 2022.
7
Thrombotic Thrombocytopenic Purpura After Ad6.COV2.S Vaccination.Ad6.COV2.S疫苗接种后发生血栓性血小板减少性紫癜
Cureus. 2022 Aug 30;14(8):e28592. doi: 10.7759/cureus.28592. eCollection 2022 Aug.
8
Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.灭活新冠疫苗接种后获得性血栓性血小板减少性紫癜：两例报告及文献综述
Vaccines (Basel). 2022 Jun 24;10(7):1012. doi: 10.3390/vaccines10071012.
9
COVID-19 Vaccines and Autoimmune Hematologic Disorders.2019冠状病毒病疫苗与自身免疫性血液系统疾病
Vaccines (Basel). 2022 Jun 16;10(6):961. doi: 10.3390/vaccines10060961.
10
Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature.基于mRNA的COVID-19疫苗BNT162b2接种后免疫介导的血栓性血小板减少性紫癜：病例报告及文献综述
Front Med (Lausanne). 2022 May 17;9:890661. doi: 10.3389/fmed.2022.890661. eCollection 2022.
获得性血栓性血小板减少性紫癜：一种与 BNT162b2 疫苗相关的罕见疾病。
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
4
First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination.首例与基于 mRNA 的抗 COVID-19 疫苗接种相关的新发免疫性血小板减少性紫癜（iTTP）发作。
J Thromb Haemost. 2021 Aug;19(8):2014-2018. doi: 10.1111/jth.15418. Epub 2021 Jul 5.
5
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015.血栓性血小板减少性紫癜：1995年至2015年的诊断标准、临床特征及长期预后
Blood Adv. 2017 Apr 6;1(10):590-600. doi: 10.1182/bloodadvances.2017005124. eCollection 2017 Apr 11.
6
Influenza-associated thrombotic microangiopathies.流感相关性血栓性微血管病。
Pediatr Nephrol. 2018 Nov;33(11):2009-2025. doi: 10.1007/s00467-017-3783-4. Epub 2017 Sep 7.
7
Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events.佐剂甲型H1N1流感疫苗接种揭示了年龄依赖性早期反应和临床不良事件的淋巴细胞特征。
Nat Immunol. 2016 Feb;17(2):204-13. doi: 10.1038/ni.3328. Epub 2016 Jan 4.